IFPMA Clinical Trials Disclosure Code Covers All Studies Of Life-Threatening Conditions
This article was originally published in PharmAsia News
Executive Summary
The International Federation of Pharmaceutical Manufacturers & Associations' Council on Nov. 10 expanded the group's clinical trials disclosure policy to cover all clinical trials, other than exploratory trials